Novartis Ag (NVS) Net Margin (2009 - 2026)
Novartis Ag (NVS) posted Net Margin of 22.65% for Q2 2026, down 6.10 percentage points from 28.75% a year earlier and down 5.38 percentage points from the prior quarter.
Novartis Ag (NVS) Net Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Novartis Ag was 28.80%, down 5.30 percentage points year-over-year; for FY2025, it came in at 25.64%, down 1.04 percentage points from FY2024.
- Annual Net Margin shows a five-year change of +9.05 percentage points (FY2020 to FY2025).
- In prior years, Novartis Ag's Net Margin was 26.68% in FY2024 (-6.00 pp), 32.68% in FY2023 (+16.20 pp), 16.48% in FY2022 (-39.67 pp) and 56.15% in FY2021 (+39.56 pp).
- Quarterly Net Margin has run from a low of 13.25% in Q2 2022 to a high of 123.26% in Q4 2021 over five years.
- On a year-over-year basis, Net Margin increased in four of the last eight quarters, with an average year-over-year change of -2.42 percentage points.
- The strongest year-over-year quarter for Net Margin in the past five years was Q4 2021, with a gain of 106.82 percentage points; the weakest was Q4 2022, with a drop of 109.40 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was 28.03% (Q1 2026), 16.98% (Q4 2025) and 47.24% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 19.55% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 19.00% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.65% |
| Mar 31, 2026 | 28.03% |
| Dec 31, 2025 | 16.98% |
| Sep 30, 2025 | 47.24% |
| Jun 30, 2025 | 28.75% |
| Mar 31, 2025 | 27.54% |
| Dec 31, 2024 | 31.88% |
| Sep 30, 2024 | 49.02% |
| Jun 30, 2024 | 25.94% |
| Mar 31, 2024 | 19.15% |
| Dec 31, 2023 | 74.24% |
| Sep 30, 2023 | 14.96% |
| Jun 30, 2023 | 20.25% |
| Mar 31, 2023 | 21.24% |
| Dec 31, 2022 | 13.86% |
| Sep 30, 2022 | 15.01% |
| Jun 30, 2022 | 13.25% |
| Mar 31, 2022 | 17.71% |
| Dec 31, 2021 | 123.26% |
| Sep 30, 2021 | 21.17% |
Novartis Ag Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();